Alcohol Use Reduction in Methadone Individuals With Hepatitis C Virus(HCV)

Completed · Phase 2

Conditions studied: Hepatitis C

In brief

The Alcohol Use Reduction in Methadone Individuals with HCV was designed to compare three different types of programs for methadone maintained men and women to determine which of the three programs is most effective for:1) reducing alcohol consumption; 2) improving knowledge of and attitudes toward the disease of hepatitis and the treatment of hepatitis; 3) improving willingness to seek medical care for hepatitis C; 4) completing the 3 sessions on alcohol use reduction; 5) completing the 3 session Hepatitis A and B vaccine; and 6) determining the number of self-reported 12 step alcohol treatment program sessions attended.

Key facts

Study ID

NCT00958763

Run by

University of California, Los Angeles

People needed

219

Starts

2006-03-01

Expected to finish

2008-12-01

Last updated by the study team

2009-08-13

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Eligible participants will be 18 - 55 years of age, enrolled at the participating methadone maintenance clinic for the past 2 months, and moderate to heavy alcohol users within the last 3 months

You may not qualify if…

• Individuals who are not within the age range, have not been enrolled in a methadone maintenance clinic for the past 2 months and were not moderate to heavy alcohol users within the last 3 months

Where it is running

• Matrix Institute — Los Angeles, California, United States
• Bay Area Addiction Research & Treatment, Inc (BAART) — Los Angeles, California, United States
• Tri-City Institute — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.